Search
for
Sort by
Research 181–210 of 1000+
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course
- ADVERSE EFFECTS OF RITLECITINIB IN ADULTS AND ADOLESCENTS WITH ALOPECIA AREATA: A LITERATURE REVIEW
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- Epidermal γδ T cells, CD8 T cells and macrophages are increased in number in alopecia areata and express BST2 as part of an interferon-driven antiviral gene signature
- Efficacy of Janus Kinase Inhibitors in Alopecia in Jordanian Patients: A Retrospective Cohort Study
- Alopecia Areata and Systemic Lupus Erythematosus: Insights From a Nationwide Case–Control Study
- Abstracts from the 2024 WDS Forum - virtual option
- Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report
- Modulating immune responses in alopecia: therapeutic insights and potential targets of antisense oligonucleotides
- Alopecia Areata Possibly Secondary to COVID-19 Vaccine
- Baricitinib in pediatric chronic immune thrombocytopenia and associated autoimmune conditions: a case report
- Uncommon Presentation of Pityriasis Rubra Pilaris of the Scalp: Clinical, Trichoscopic, and Histopathologic Features and Review of the Literature
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- A rare manifestation of STING-associated vasculopathy with onset in infancy: a case report
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib
- Advances in the mechanism and new therapies of alopecia areata
- Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- Citrullination at the Inflammatory Skin Barrier
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
- Expression of Signal Transducer and Activator of Transcription-3 in Androgenetic Alopecia: A case control study
- 63-Year-Old Female with Diffuse Thinning of the Hair
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review
- Hypohidrotic Ectodermal Dysplasia with c.28delG Mutation in Ectodysplasin A Gene and Severe Atopic Dermatitis Treated Successfully with Tofacitinib
- A clinician’s guide to pediatric and adolescent alopecia areata treatments
- Discontinuation and restart of Janus kinase inhibitors due to pregnancy in alopecia areata: a case series
- Dermatological diseases from a genetic perspective